Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave — Morristown, New Jersey

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave is a clinical research site located in Morristown, New Jersey, United States 07960.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Dravet Syndrome, Developmental and Epileptic Encephalopathy.

Sponsors: Longboard Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Morristown

Browse all research sites in New Jersey · View every site in Morristown

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave conducted?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has 3 clinical trials on record, with 3 currently active. Their work covers Dravet Syndrome, Developmental and Epileptic Encephalopathy.

Is Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave accredited by Crixeo Clinical Trials?

Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.